Fintel reports that on February 4, 2025, Piper Sandler downgraded their outlook for Amphastar Pharmaceuticals (NasdaqGS:AMPH) ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...